Fibroblast growth factor receptor 1 (FGFR1) protein expression recently has been associated with poor prognosis of ER+/HER2-negative (HER2-) and triple-negative breast cancer [15–17]. The gene discussed is FGFR1; the disease is triple-negative breast carcinoma.